Company: PCRX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001104659-25-041219
Chunk: 63

Company: Pacira BioSciences, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 63
---
 employees with a title of Vice President or below, provided that such grants are reviewed periodically by the People & Compensation Committee). It is the People & Compensation Committee’s philosophy that maintaining a consistent and formulaic grant practice, based on both its long-standing cadence and board meeting dates that are set in advance, is in the best interests of the Company and its stockholders. Any deviation from these practices is at the discretion of the board or the People & Compensation Committee. While the People & Compensation Committee has discretionary authority to grant equity awards outside of the cycle described above, it does not have a practice or policy of granting equity awards in anticipation of the release of material non-public informationand, in any event, we do not timethe release of material non-public information in coordination with grants of equity awards in a manner that intentionally affects the value of executive compensation.In addition, we do not take material nonpublic information into account when determining the timing and terms of our equity awards. Although we do not have a formal policy with respect to the timing of our equity award grants, the People & Compensation Committee has historically granted such awards on a predeterminedschedule. Pursuant to Item 402(x) of Regulation S-K, the following table includes information related to stock options awarded to our named executive officers during 2024 within four business days before the filing of the Company’s annual report on Form 10-K, a periodic report on Form 10-Q, or the filing or furnishing of a current report on Form 8-K that disclosed material nonpublic information and ending one business day after the filing or furnishing of such report.

| Name            | ​ | ​ | Grant Date |   |           |   |   | ​ | ​ | Number ofSecuritiesUnderlyingthe Award |   |         |   |   | ​ | ​ | Exercise Priceof the Award($/sh) |   |       |   |   | ​ | ​ | Grant DateFair Valueof the Award($) |   |           |   |   | ​ | ​ | Percentage change in theclosing market price ofthe securities underlying the awardbetween the trading day endingimmediately prior to the disclosureof material nonpublic informationand the trading day beginningimmediately following the disclosureof material nonpublic information(%) |   |     |   |   | ​ |
|:----------------|:--|:--|:-----------|:--|:----------|:--|:--|:--|:--|:---------------------------------------|:--|--------:|: